DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,490,397 | +8.6% | 74,528 | +5.1% | 1.06% | +11.4% |
Q2 2023 | $17,026,800 | -3.5% | 70,945 | +1.3% | 0.95% | -9.8% |
Q1 2023 | $17,651,621 | +1.5% | 70,035 | +6.9% | 1.06% | -11.8% |
Q4 2022 | $17,393,769 | +7.2% | 65,533 | +4.3% | 1.20% | +5.9% |
Q3 2022 | $16,232,000 | +18.1% | 62,845 | +15.9% | 1.13% | +9.4% |
Q2 2022 | $13,747,000 | -6.6% | 54,225 | +8.0% | 1.04% | +23.4% |
Q1 2022 | $14,723,000 | -11.8% | 50,193 | -1.1% | 0.84% | -1.1% |
Q4 2021 | $16,700,000 | +7.3% | 50,757 | -0.7% | 0.85% | +0.1% |
Q3 2021 | $15,564,000 | +12.2% | 51,124 | -1.1% | 0.85% | +10.9% |
Q2 2021 | $13,870,000 | +24.1% | 51,686 | +4.1% | 0.76% | +13.2% |
Q1 2021 | $11,179,000 | +0.3% | 49,667 | -1.0% | 0.68% | +3.7% |
Q4 2020 | $11,146,000 | -1.5% | 50,174 | -4.5% | 0.65% | -15.1% |
Q3 2020 | $11,315,000 | +45.5% | 52,546 | +19.4% | 0.77% | +5.4% |
Q2 2020 | $7,779,000 | +28.3% | 43,992 | +0.5% | 0.73% | +7.1% |
Q1 2020 | $6,061,000 | -10.1% | 43,787 | -0.4% | 0.68% | -4.2% |
Q4 2019 | $6,745,000 | +51.8% | 43,945 | +42.9% | 0.71% | +5.7% |
Q3 2019 | $4,442,000 | +115.7% | 30,757 | +113.4% | 0.67% | +37.4% |
Q2 2019 | $2,059,000 | +15.8% | 14,410 | +7.0% | 0.49% | +14.8% |
Q1 2019 | $1,778,000 | +89.4% | 13,468 | +48.0% | 0.43% | +67.1% |
Q4 2018 | $939,000 | -14.7% | 9,103 | -10.1% | 0.26% | -25.9% |
Q3 2018 | $1,101,000 | -73.5% | 10,130 | -76.0% | 0.34% | -52.7% |
Q2 2018 | $4,158,000 | -8.2% | 42,131 | -8.9% | 0.73% | -10.4% |
Q1 2018 | $4,530,000 | +5.5% | 46,265 | 0.0% | 0.81% | -0.4% |
Q4 2017 | $4,295,000 | -86.8% | 46,265 | -87.8% | 0.81% | -62.2% |
Q3 2017 | $32,641,000 | +1.0% | 380,520 | -0.6% | 2.15% | +0.6% |
Q2 2017 | $32,315,000 | +2.8% | 382,920 | +4.2% | 2.14% | +4.6% |
Q1 2017 | $31,425,000 | +11.0% | 367,410 | +1.0% | 2.05% | +3.3% |
Q4 2016 | $28,311,000 | +5.5% | 363,710 | +6.2% | 1.98% | +4.5% |
Q3 2016 | $26,842,000 | -22.4% | 342,410 | 0.0% | 1.90% | -24.3% |
Q2 2016 | $34,583,000 | +5.4% | 342,410 | -1.0% | 2.50% | +18.3% |
Q1 2016 | $32,804,000 | +0.2% | 345,810 | -1.9% | 2.12% | +2.3% |
Q4 2015 | $32,750,000 | +10.3% | 352,610 | +1.2% | 2.07% | +5.0% |
Q3 2015 | $29,687,000 | +0.2% | 348,400 | +0.6% | 1.97% | +12.8% |
Q2 2015 | $29,640,000 | +0.8% | 346,300 | 0.0% | 1.75% | -2.5% |
Q1 2015 | $29,401,000 | -5.9% | 346,300 | -5.0% | 1.79% | -5.8% |
Q4 2014 | $31,233,000 | -3.7% | 364,400 | -14.6% | 1.90% | -5.6% |
Q3 2014 | $32,428,000 | -3.9% | 426,800 | -0.4% | 2.02% | -3.3% |
Q2 2014 | $33,744,000 | -19.2% | 428,600 | -23.0% | 2.09% | -20.3% |
Q1 2014 | $41,768,000 | -5.9% | 556,900 | -3.1% | 2.62% | -3.6% |
Q4 2013 | $44,367,000 | +7.6% | 574,700 | -3.4% | 2.71% | +0.4% |
Q3 2013 | $41,225,000 | +1.6% | 594,700 | -7.2% | 2.70% | +8.0% |
Q2 2013 | $40,582,000 | – | 641,100 | – | 2.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
Third Point | 2,900,000 | $954,129,000 | 6.66% |
Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |